monoclonal antibody
C7047
concept
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
All labels observed (24)
| Label | Occurrences |
|---|---|
| monoclonal antibody canonical | 51 |
| biologic drug | 14 |
| therapeutic antibody | 8 |
| biosimilar medicine | 4 |
| monoclonal antibody drug | 4 |
| HER2-targeted therapy | 3 |
| bispecific monoclonal antibody | 3 |
| immunotherapy | 3 |
| monoclonal antibody cocktail | 3 |
| CD38-targeting antibody | 2 |
| anti-VEGF agent | 2 |
| immune checkpoint inhibitor | 2 |
| rituximab biosimilar | 2 |
| rituximab-containing medicinal product | 2 |
| CD20-directed cytolytic antibody | 1 |
| anti‑CD20 antibody | 1 |
| anti‑angiogenic agent | 1 |
| cancer immunotherapy | 1 |
| chimeric monoclonal antibody | 1 |
| human IgG4 monoclonal antibody | 1 |
| human monoclonal antibody | 1 |
| humanized monoclonal antibody | 1 |
| immunoglobulin G1 | 1 |
| monoclonal antibody fragment | 1 |
Description generation (CDg)
The one-sentence description above was generated by prompting gpt-5.1 with the class name and this instruction.
Instruction
generate a one-sentence description for a given conceptual class. # Response Format Return only the sentence: "Description: [one-sentence description of the conceptional class]"
Input
Class: monoclonal antibody
Generated description
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
Instances (68)
| Instance | Via concept surface |
|---|---|
| REGN-EB3 | monoclonal antibody cocktail |
| mAb114 | — |
|
aducanumab
linked to:
Eisai and Biogen
|
— |
|
Tysabri
linked to:
Elan Pharmaceuticals
|
monoclonal antibody drug |
| Taltz | — |
| Emgality | — |
| MabThera | — |
| faricimab | — |
| aflibercept | biologic drug |
| diphtheria antitoxin | immunotherapy |
| andexanet alfa | biologic drug |
| Inflectra | biologic drug |
| Renflexis | biologic drug |
| Ixifi | — |
| Avsola | biosimilar medicine |
| Tysabri | — |
| Aduhelm | — |
| Leqembi | — |
| Ruxience | — |
| Riabni | — |
| pertuzumab | — |
| Avastin | — |
| Herceptin | — |
| Rituxan | — |
| Perjeta | monoclonal antibody drug |
| Lucentis | biologic drug |
| Xolair | — |
| Tecentriq | cancer immunotherapy |
| Keytruda | immunotherapy |
| maftivimab | — |
| odesivimab | — |
| Inmazeb | monoclonal antibody cocktail |
| ansuvimab | — |
| Ebanga | — |
| Synagis | — |
| Remicade | biologic drug |
| Darzalex | monoclonal antibody drug |
| Stelara | — |
| Imfinzi | immune checkpoint inhibitor |
| Fasenra | — |
| ocrelizumab | — |
| bapineuzumab | — |
|
Tysabri
linked to:
ELN
|
monoclonal antibody drug |
| Dupixent | — |
| Eylea | biologic drug |
| Libtayo | — |
| Kevzara | — |
| REGN-COV2 | monoclonal antibody cocktail |
| Humira | — |
| Skyrizi | — |